Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, May 13, 2026 (GLOBE NEWSWIRE) -- The "Australia Telehealth Market - Distribution by Component, Type of Delivery Mode, Application and End-user: Industry Trends and Global Forecasts, till...
-
Felix to lower semaglutide pricing by up to 65% as generic options enter Canada, helping improve affordability for weight management patients.
-
Austin, TX, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Clinical Informatics Market Size, Trends and Insights By Type (Electronic Health...
-
Gala GLP-1 scam or legit? Compounded GLP-1/GIP from $179/mo. Licensed provider review. No insurance. No prescription guarantee. All 50 states.
-
(OTCPK: MAJI) announce the commencement of the final stability phase for its inaugural line of commercial exosome products.
-
Novi GLP-1 offers compounded semaglutide from $133 and tirzepatide from $166 with licensed clinician review. Pricing, eligibility, and terms evaluated.
-
Fort Worth, TX, May 07, 2026 (GLOBE NEWSWIRE) -- MedTech Breakthrough is honoring TimelyCare, education’s most trusted virtual care provider, as the winner of the “Best Overall TeleHealth Solution”...
-
Gala Health under investigation? Compounded tirzepatide & HRT telehealth: $149/mo, all 50 states, no insurance, licensed providers.
-
Bicycle Health Expands Leadership Team to Increase Access to Evidence-Based Opioid Use Disorder Care
ATLANTA, May 05, 2026 (GLOBE NEWSWIRE) -- Bicycle Health, the nation’s leading technology-enabled virtual medical group delivering evidence-based treatment for opioid use disorder (OUD), today...
-
Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "The Telecare Market in Europe and North America - 2nd Edition" report has been added to ResearchAndMarkets.com's offering. The report estimates...